Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that men with early-onset androgenetic alopecia may experience less benefit from rosuvastatin treatment in terms of improving cardiometabolic risk factors compared to men with normal hair growth.

This clinical trial found that topical rosuvastatin and melatonin creams significantly reduced the severity of mild to moderate plaque psoriasis over 12 weeks, with a satisfactory safety profile.

In this study, researchers developed and optimized squarticles containing rosuvastatin calcium and found that they promoted hair regrowth in rats within 10 days, showing superior results compared to the standard minoxidil treatment.

This study found that a pathogenetically-based treatment using drugs to correct dyslipidemia and insulin resistance in conjunction with basic therapy led to better outcomes for alopecia areata patients with metabolic syndrome.